Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 12,973-12,984 of 23,847
Other study type icon
CompletedNCT05207319

Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Kaohsiung City
SchizophreniaOtherFrom 20 Years to 65 Years
Countries
Taiwan
Sponsor
I-Shou University
Condition
Schizophrenia
Drug study icon
CompletedNCT03943537

Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in people with Psychotic Disorders

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can better support energy, concentration, and everyday functioning.

In Belmont
Schizophrenia, BipolarityDrugA study involving a medication or substance.From 18 Years to 40 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT02595749

Effects of Intranasal Oxytocin on Cigarette Smoking

This summary needs review. Please check the official study record and contact the research team for details.

In Los Angeles
AddictionDrugFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of Southern California
Condition
Addiction
Drug study icon
Active Not RecruitingNCT04846829

Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)

This study is looking at recruit 30 subjects diagnosed with Major Depressive Disorder (depression) for people with depression. Participants receive Placebo or placebo and complete study visits and assessments.

In Los Angeles
DepressionDrugFrom 21 Years to 55 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
Drug study icon
CompletedNCT01140620

Effects of Ketamine and Risperidone on Cognition

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including London
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
University of Manchester
Condition
Schizophrenia
Drug study icon
CompletedNCT02299440

Effects of Ketamine in the Acute Phase of Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Clermont-Ferrand
SuicidalityOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Condition
Suicidality
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.